R
Robert Gallop
Researcher at West Chester University of Pennsylvania
Publications - 266
Citations - 20875
Robert Gallop is an academic researcher from West Chester University of Pennsylvania. The author has contributed to research in topics: Randomized controlled trial & Cognitive therapy. The author has an hindex of 66, co-authored 244 publications receiving 18743 citations. Previous affiliations of Robert Gallop include University of Ottawa & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder
Marsha M. Linehan,Katherine Anne Comtois,Angela Murray,Milton Z. Brown,Robert Gallop,Heidi L. Heard,Kathryn E. Korslund,Darren A. Tutek,Sarah K. Reynolds,Noam Lindenboim +9 more
TL;DR: In this article, Dialectical behavior therapy (DBT) was shown to be more effective in reducing suicidal behavior and borderline personality disorder compared with non-behavioral psychotherapy experts.
Journal ArticleDOI
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.
Sona Dimidjian,Steven D. Hollon,Keith S. Dobson,Karen B. Schmaling,Robert J. Kohlenberg,Michael E. Addis,Robert Gallop,Joseph B. McGlinchey,David K. Markley,Jackie K. Gollan,David C. Atkins,David L. Dunner,Neil S. Jacobson +12 more
TL;DR: Among more severely depressed patients, behavioral activation was comparable to antidepressant medication, and both significantly outperformed cognitive therapy, and the implications of current treatment guidelines and dissemination are discussed.
Journal ArticleDOI
Cognitive therapy vs medications in the treatment of moderate to severe depression.
Robert J. DeRubeis,Steven D. Hollon,Jay D. Amsterdam,Richard C. Shelton,Paula R. Young,Ronald M. Salomon,John P. O'Reardon,Margaret L. Lovett,Madeline M. Gladis,Laurel L. Brown,Robert Gallop +10 more
TL;DR: Cognitive therapy can be as effective as medications for the initial treatment of moderate to severe major depression, but this degree of effectiveness may depend on a high level of therapist experience or expertise.
Journal ArticleDOI
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
Steven D. Hollon,Robert J. DeRubeis,Richard C. Shelton,Jay D. Amsterdam,Ronald M. Salomon,John P. O'Reardon,Margaret L. Lovett,Paula R. Young,Kirsten L. Haman,Brent B. Freeman,Robert Gallop +10 more
TL;DR: Cognitive therapy has an enduring effect that extends beyond the end of treatment and seems to be as effective as keeping patients on medication.
Journal ArticleDOI
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Chang-Gyu Hahn,Hoau-Yan Wang,Dan-Sung Cho,Konrad Talbot,Raquel E. Gur,Wade H. Berrettini,Kalindi Bakshi,Joshua Kamins,Karin E. Borgmann-Winter,Steven J. Siegel,Robert Gallop,Steven E. Arnold +11 more
TL;DR: In this article, a postmortem tissue-stimulation approach was used to find an increase in NRG1-induced activation of erbB4 in the prefrontal cortex in schizophrenia.